JAK1 inhibitor: A promising option for patients with pigmented purpuric dermatoses.

Subjects

Subjects :

Humans
Purpura drug therapy
Male
Female
Janus Kinase Inhibitors therapeutic use
Middle Aged
Pigmentation Disorders drug therapy
Janus Kinase 1 antagonists & inhibitors

Details

Language :

English

ISSN :

1468-3083

Volume :

38

Issue :

5

Database :

MEDLINE

Journal :

Journal of the European Academy of Dermatology and Venereology : JEADV

Publication Type :

Report

Accession number :

37908169

Full Text :

https://doi.org/10.1111/jdv.19616